Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

The Tumor Associated Antigen PRAME Exhibits Dualistic Functions That Are Targetable in Diffuse Large B-Cell Lymphoma

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-141168

Published: 2020

Journal Articles

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Blood (2019) 134 (Supplement_1): 350.

https://doi.org/10.1182/blood-2019-126798

Published: 2019

Journal Articles

TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP

Pedro Farinha, MD PhD, Daisuke Ennishi, MD PhD, Anja Mottok, MD PhD, Susana Ben-Neriah, BSc, Barbara Meissner, PhD, Merrill Boyle, BSc, Jeffrey W. Craig, MD PhD, Graham W Slack, MD, Diego Villa, MD MPH, Kerry J Savage, BSc, MD MSc, Laurie H Sehn, MD, Ryan D. Morin, PhD, Marco A. Marra, PhD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Christian Steidl, MD, David W. Scott, MBChB, PhD

Blood (2019) 134 (Supplement_1): 3964.

https://doi.org/10.1182/blood-2019-121943

Published: 2019

Journal Articles

Molecular Correlates of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Robert Kridel, MDMPH,PhD, Keren Isaev, MSc, Daisuke Ennishi, MD PhD, Brian Skinnider, MD, Karen Mungall, PhD, Andrew J. Mungall, PhD, Mehran Bakhtiari, MSc, Rosemarie Tremblay-Lemay, MD MSc, FRCPC, Barbara Meissner, PhD, Susana Ben-Neriah, BSc, Merrill Boyle, BSc, Diego Villa, MD MPH, Marco A. Marra, PhD, Christian Steidl, MD, Randy D. Gascoyne, MD, Kerry J Savage, BSc, MD MSc, David W. Scott, MBChB, PhD

Blood (2019) 134 (Supplement_1): 2763.

https://doi.org/10.1182/blood-2019-124235

Published: 2019

Journal Articles

Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome

Gerben Duns, PhD, Elena Viganò, PhD, Daisuke Ennishi, MD PhD, Clementine Sarkozy, MD, Stacy Hung, Elizabeth Chavez, Katsuyoshi Takata, MD PhD, Anja Mottok, MD PhD, Randy D. Gascoyne, MD, Ryan D. Morin, PhD, Kerry J Savage, BSc, MD MSc, David W. Scott, MBChB, PhD, Christian Steidl, MD

Blood (2019) 134 (Supplement_1): 922.

https://doi.org/10.1182/blood-2019-131450

Published: 2019

Journal Articles

Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype

Daisuke Ennishi, MD PhD, Anja Mottok, MD, Kerry J. Savage, MDMSc, Susana Ben-Neriah, Hennady Shulha, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, Merrill Boyle, BSc, Christoffer E Hother, MD PhD, Robert Kridel, MD MPH, Ryan Morin, PhD, Marco A Marra, PhD, Laurie H. Sehn, Christian Steidl, MD, Joseph M. Connors, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne

Blood (2015) 126 (23): 109.

https://doi.org/10.1182/blood.V126.23.109.109

Published: 2015

Journal Articles

Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma

Daisuke Ennishi, MD PhD, Anja Mottok, MD, Hennady Shulha, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, Merrill Boyle, BSc, Susana Ben-Neriah, Christoffer E Hother, MD PhD, Robert Kridel, MD MPH, Ryan Morin, PhD, Marco A Marra, PhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, Joseph M. Connors, MD, Christian Steidl, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne

Blood (2015) 126 (23): 111.

https://doi.org/10.1182/blood.V126.23.111.111

Published: 2015

Journal Articles

Mass Cytometry Based Classification of Inter- and Intra-Tumoral Heterogeneity in Diffuse Large B-Cell Lymphoma

Manabu Kusakabe, MDPhD, Xuehai Wang, PhD, Guillermo Simkin, PhD, Justin Meskas, MSc, Chaoran Zhang, Daisuke Ennishi, MD PhD, Robert Kridel, MD MPH, Merrill Boyle, BSc, Elizabeth Chavez, BSc, Stacy Hung, PhD, David W Scott, MBChB, PhD, Christian Steidl, MD, Randy D. Gascoyne, Ryan R. Brinkman, PhD, Andrew P Weng, MD PhD

Blood (2015) 126 (23): 3908.

https://doi.org/10.1182/blood.V126.23.3908.3908

Published: 2015

Journal Articles

Single Cell Mass Cytometry for Phenotypic Analysis of Diffuse Large B-Cell Lymphoma

Manabu Kusakabe, MD PhD, Guillermo Simkin, PhD, Justin Meskas, MSc, Chaoran Zhang, Daisuke Ennishi, MD PhD, Merrill Boyle, B.Sc., David W. Scott, MBChB, PhD, Christian Steidl, MD, Randy D. Gascoyne, MD, Ryan R. Brinkman, Andrew P Weng, MD PhD

Blood (2014) 124 (21): 2976.

https://doi.org/10.1182/blood.V124.21.2976.2976

Published: 2014

Journal Articles

Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma

Daisuke Ennishi, MD PhD, Christoffer Hoffer, Hennady Shulha, Anja Mottok, MD, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, PhD, Merrill Boyle, B.Sc., Susana Ben-Neriah, MSc, Ryan D Morin, PhD, Marco A. Marra, PhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Joseph M Connors, MD, Christian Steidl, MD, David W. Scott, MBChB, PhD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 703.

https://doi.org/10.1182/blood.V124.21.703.703

Published: 2014

Journal Articles

Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry

David W. Scott, MBChB, PhD, Anja Mottok, MD, Daisuke Ennishi, MD PhD, George W. Wright, PhD, Pedro Farinha, MD, Susana Ben-Neriah, MSc, Robert Kridel, MD MPH, Garrett S Barry, B.Sc, Christoffer E Hother, MDPhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Louis M. Staudt, Joseph M. Connors, MD, Lisa M. Rimsza, MD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 1624.

https://doi.org/10.1182/blood.V124.21.1624.1624

Published: 2014

Journal Articles

Genetic Alterations In Immune Cell Crosstalk Genes In Diffuse Large B-Cell Lymphoma Predict Survival

Daisuke Ennishi, MD, PhD, Fong Chun Chan, MSc, David W. Scott, MBChB PhD, Christoffer Hother, MD, PhD, Barbara Meissner, PhD, Merrill Boyle, B.Sc., Ryan D Morin, Laurie H. Sehn, MD, MPH, Marco A. Marra, PhD, Joseph M. Connors, MD, Christian Steidl, MD, Randy D. Gascoyne, MD

Blood (2013) 122 (21): 500.

https://doi.org/10.1182/blood.V122.21.500.500

Published: 2013

Journal Articles

Addition of Rituximab to CHOP Chemotherapy Does Not Improve Clinical Outcome in Patients with Localized Gastric Diffuse Large B-Cell Lymphoma: A Retrospective Study by Ganken Adult Lymphoma Study Group (Single Institute Analysis).

Masahiro Yokoyama, MD, Daisuke Ennishi, MD, Hiroaki Asai, MD, Kyoko Ueda, MD, Makoto Kodaira, MD, Shuhei Yamada, MD, Tomohiro Myojo, MD, Yuko Mishima, MD, Sakura Sakajiri, MD, PhD, Kengo Takeuchi, MD, PhD, Takashi Saotome, MD, Yasuhito Terui, MD, PhD, Shunji Takahashi, MD, PhD, Yoshinori Ito, MD, PhD, Kiyohiko Hatake, MD, PhD

Blood (2007) 110 (11): 4449.

https://doi.org/10.1182/blood.V110.11.4449.4449

Published: 2007

Journal Articles

Rituximab-CHOP Significantly Improve the Response of Advanced Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT Lymphoma).

Daisuke Ennishi, MD, Yasuhito Terui, MD,PhD, Tomohiro Myojo, MD, Yuko Mishima, MD, Masahiro Yokoyama, MD, Shunji Takahashi, MD,PhD, Kengo Takeuchi, MD,PhD, Kiyohiko Hatake, MD,PhD

Blood (2006) 108 (11): 4715.

https://doi.org/10.1182/blood.V108.11.4715.4715

Published: 2006

Journal Articles

Addition of Rituximab to CHOP Regimen Improves Clinical Outcome in Non-Germinal Center Type Diffuse Large B-Cell Lymphoma.

Masahiro Yokoyama, MD, Daisuke Ennishi, MD, Kyoko Ueda, MD, Makoto Kodaira, MD, Shuhei Yamada, MD, Tomohiro Myojo, MD, Sakura Sakajiri, MD, Yuko Mishima, MD, Kengo Takeuchi, PHD, Takashi Saotome, MD, Yasuhito Terui, MD, Shunji Takahashi, MD, Yoshinori Ito, MD, Kiyohiko Hatake, MD

Blood (2006) 108 (11): 4725.

https://doi.org/10.1182/blood.V108.11.4725.4725

Published: 2006

NARROW

The Tumor Associated Antigen PRAME Exhibits Dualistic Functions That Are Targetable in Diffuse Large B-Cell Lymphoma

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP

Molecular Correlates of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome

Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype

Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma

Mass Cytometry Based Classification of Inter- and Intra-Tumoral Heterogeneity in Diffuse Large B-Cell Lymphoma

Single Cell Mass Cytometry for Phenotypic Analysis of Diffuse Large B-Cell Lymphoma

Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma

Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry

Genetic Alterations In Immune Cell Crosstalk Genes In Diffuse Large B-Cell Lymphoma Predict Survival

Addition of Rituximab to CHOP Chemotherapy Does Not Improve Clinical Outcome in Patients with Localized Gastric Diffuse Large B-Cell Lymphoma: A Retrospective Study by Ganken Adult Lymphoma Study Group (Single Institute Analysis).

Rituximab-CHOP Significantly Improve the Response of Advanced Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT Lymphoma).

Addition of Rituximab to CHOP Regimen Improves Clinical Outcome in Non-Germinal Center Type Diffuse Large B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only